In Parkinson’s disease and dementia with Lewy bodies, pathological aggregates of misfolded alpha-synuclein protein develop in brain neurons. Researchers have now described changes in hippocampal neurons early after the aggregates begin to appear. This understanding, combined with further exploration of the mechanisms underlying the neuronal changes, could point to novel therapeutic treatments to prevent or reverse neuronal defects and halt development of dementia.